Byers, Spencer
Buchler, Ingrid P.
DePasquale, Michael
Rowley, Helen L.
Kulkarni, Rajiv S.
Pinder, Lucy
Kolobova, Anna
Li, Cailian
Au, Vinh
Akuma, Daniel
Zhang, Gongliang
Wei, Huijun
Cheetham, Sharon C.
Barrow, James C.
Carr, Gregory V. http://orcid.org/0000-0002-6091-6729
Funding for this research was provided by:
National Institute of Mental Health (R01MH107126)
Article History
Received: 13 March 2019
Accepted: 20 May 2020
First Online: 30 May 2020
Compliance with ethical standards
: All procedures were approved by the local Animal Care and Use Committee and were in compliance with the <i>Guide for the Care and Use of Laboratory Animals</i>.
: IPB and JCB are inventors on patents that include the novel COMT inhibitors (WO2016123576 and WO2017091818). HLR, RSK, LP, and SCC are employees of RenaSci Ltd. The remaining authors have nothing to disclose.